Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T108 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T142 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T143 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T97 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | W. C. Brucker et al., Zurich Open Repository and Archive, University of Zurich, 2012, doi.org/10.1038/onc.2011.530 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C. Wanka et al., J. Biol. Chem., Sep 2012; 287: 33436 - 33446 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | ||
TAM6 |
Human breast adenocarcinoma cell line (MCF-7 clone) | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 | Link | |||
TCA8113 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | |||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | N. Mukhamedova et al., J. Lipid Res., Nov 2008; 49: 2312 - 2322 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | RNA-Interference | Metafectene | publication | M.-H. Chien et al., Carcinogenesis, Dec 2009; 30: 2005 - 2013 | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | |||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TPC1 |
Human thyroid gland papillary carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. Rizzi et al., The J. of Comparative Neurology, 2016, 524:2093-2116; DOI 10.1002/cne.23934 | Link | |||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
TT |
Human medullary thyroid carcinoma cell line | ATCC CRL-1803 | Human | other | cell line | adherent | plasmid | Metafectene | publication | T. Takahashi et al., J. Biochem., Nov 2009; 146: 675 - 682 | |||
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. Dietschy et al., J. Cell Sci., Apr 2009; 122: 1258 - 1267 | Link |